ROIV – roivant sciences ltd. (US:NASDAQ)
Stock Stats
News
Vivek Ramaswamy's Net Worth Has Nearly Doubled While He's Running For Ohio Governor [Forbes]
Roivant Sciences (NASDAQ:ROIV) was upgraded by analysts at Wall Street Z
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Roivant Sciences: Brepocitinib And Roadmap Still Underpriced [Seeking Alpha]
Roivant Sciences (NASDAQ:ROIV) had its price target raised by analysts at Citigroup Inc. from $25.00 to $26.00. They now have a "buy" rating on the stock.
Form 4 Roivant Sciences Ltd. For: Nov 20 Filed by: Pulik Richard
Form 4 Roivant Sciences Ltd. For: Nov 20 Filed by: Venker Eric
Form 4 Roivant Sciences Ltd. For: Nov 19 Filed by: MANCHESTER KEITH S
Form 4 Roivant Sciences Ltd. For: Nov 19 Filed by: Gold Daniel Allen
Form 4 Roivant Sciences Ltd. For: Nov 19 Filed by: QVT Financial LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.